ARTICLE | Company News
NDA for PA21 submitted to FDA
February 12, 2013 12:49 AM UTC
Galenica Ltd. (SIX:GALN) and its specialty pharma business Vifor Pharma Ltd. said an NDA was submitted to FDA for PA21 to treat hyperphosphatemia in patients with chronic kidney disease (CKD). Separat...